These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4133958)

  • 1. [Analgesic therapy of arteriopathies].
    Rossano C; Testasecca D; Giuliano F; De Luca PF
    Minerva Med; 1974 Mar; 65(24):1286-9. PubMed ID: 4133958
    [No Abstract]   [Full Text] [Related]  

  • 2. [On prolonged hemokinetic therapy of occlusive arterial diseases].
    Alegría A
    Med Klin; 1965 Jul; 60(28):1126-31. PubMed ID: 5835983
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy of arterial circulatory disorders with Lioftal].
    Greif S
    Munch Med Wochenschr; 1969 May; 111(18):1055-8. PubMed ID: 5819199
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with Complamine in vascular diseases of the fundus oculi].
    Fronimopoulos J; Cofinas H; Lambrou N
    Klin Monbl Augenheilkd; 1967; 151(2):201-7. PubMed ID: 5592110
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of arteriopathies of limbs by xanthinol nicotinate].
    Elbaz C
    Phlebologie; 1969; 22(1):105-11. PubMed ID: 5775643
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of arterial occlusion diseases with intraarterial injections in the practice].
    Apel G
    Arzneimittelforschung; 1969 Aug; 19(8):1310-2. PubMed ID: 5820299
    [No Abstract]   [Full Text] [Related]  

  • 7. [Compensation grade of arterial occlusions and action of intravenously administered vasoactive drugs].
    Bollinger A; Lüthy E
    Helv Med Acta Suppl; 1967 May; 47():128. PubMed ID: 5286297
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modification of the vascular changes of the ocular fundus by xantinol nicotinate].
    von Grósz I; Födö V
    Med Welt; 1969 Aug; 35():1916-7. PubMed ID: 5809867
    [No Abstract]   [Full Text] [Related]  

  • 9. [Xanthinol-nicotinate (complamine)].
    Cas Lek Cesk; 1968; 107(51):1567-8. PubMed ID: 5700857
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analysis of the pharmacodynamic properties of the nicotinic ester of 7-(2-hydroxyethyl)-theophylline. II. Cardiocirculatory effects in subjects with cerebral and peripheral angiopathies].
    De Gregorio G; Scaffidi L; Arcoraci A
    Cardiol Prat; 1971 Oct; 22(5):329-36. PubMed ID: 5136470
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacodynamic study on nicotinic acid and of one of its higher homologs (3-pyridyl acetic acid) in obliterative arteriopathies of the extremities].
    Spanò G; Saponaro A; Giordano G; Verde AM; Cosentino F; Dagianti A
    Boll Soc Ital Cardiol; 1967; 12(2):148-53. PubMed ID: 5606866
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic experiences with an adenosine-theophylline Sodium-nicotinate combination in peripheral circulation disorders].
    Weber G; Vogel A
    Dermatol Wochenschr; 1967 Nov; 153(46):1278-82. PubMed ID: 5588908
    [No Abstract]   [Full Text] [Related]  

  • 13. [The action of xanthinol nicotinate on the peripheral circulation of the aged].
    Chevat H; Steenhouwer B; Hiltenbrand C; Legrand MF; Graux P
    Angeiologie; 1968; 20(2):33-42. PubMed ID: 5682235
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and instrumental observations on the hemodynamic activity of a new drug: 7-(2-(3-pyridyl-methylamino)-ethyl)-theophylline nicotinate].
    Jovino R; Renda A
    Minerva Cardioangiol; 1971 Dec; 19(12):709-18. PubMed ID: 5129037
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of a xanthine derivative in peripheral arterial blood flow disorders].
    de Weger WP
    Med Monatsschr; 1970 May; 24(5):221-5. PubMed ID: 5512478
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of complamin on the disturbances of peripheral circulation in the light of rheoangiographic studies and measurement of skin temperature].
    Dryjski J; Wesolowski J
    Pol Tyg Lek; 1966 Dec; 21(50):1928-30. PubMed ID: 5979808
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences with a new vasodilator: 3-(methylhydroxyethylamino)-2-hydroxypropyltheophylline nicotinate].
    Sideri GC; Fumagalli G; Locatelli R
    Arch Patol Clin Med; 1965 Jun; 41(6):479-83. PubMed ID: 5319767
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience with Complamin in peripheral circulation disorders].
    Wittenburg H
    Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complamine in obliterating peripheral circulatory disorders].
    Kusztos D; Bereczky M; Fono J
    Med Monatsschr; 1970 Mar; 24(3):127-8. PubMed ID: 5436974
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the therapy of various hearing disorders of the sound-perception type].
    Sinzinger G
    Monatsschr Ohrenheilkd Laryngorhinol; 1967; 101(4):145-57. PubMed ID: 5586337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.